June 16 Interpace Diagnostics Group Inc :
* Interpace Diagnostics announces pricing of $13.7 million underwritten public offering of common stock and common warrants
* Interpace Diagnostics Group Inc - pricing of an underwritten public offering of 12.5 million shares of its common stock
* Interpace Diagnostics Group Inc - common warrants will be immediately exercisable at a price of $1.25 per share of common stock Source text for Eikon: Further company coverage:
UPDATE 2-Investors call on Mylan chairman, director to step down
NEW YORK, June 28 An investor group led by New York City's comptroller called for Mylan NV's Chairman Robert Coury and Director Wendy Cameron to step down, as part of a campaign against the firm's executive pay packages and high prices for an allergy treatment.
BRIEF-Dova Pharmaceuticals prices IPO at $17/share
* Dova Pharmaceuticals Inc Announces pricing of initial public offering